Fertility Tech

Long-term demographic changes are finally bringing fertility technologies into focus.

Overview

Apps and services aimed at fertility tracking, monitoring, and preservation

Fertility tech refers to technology driven solutions used by men and women to monitor or preserve fertility. Fertility monitoring helps couples increase their chance of conceiving. Fertility preservation reduces the impact of one’s biological clock when making decisions on conceiving and family planning. The fertility tech ecosystem also includes players who support the fertility tech industry by offering patients assistance in navigating their fertility care decision-making and financing. These tech tools are gaining traction supported by several demographic, social, and economic factors such as delaying parenthood, decreasing male fertility, and a shortage of fertility clinics.

Industry Updates

View all updatesicon
Market Sizing

The US Fertility Tech market could reach USD 2.9 billion–4.9 billion by 2028

Conservative case

USD 0.0 Bn

Base case

USD 0.0 Bn

Expansion case

USD 0.0 Bn

Market Mapping


The fertility tech market primarily includes products engaged in fertility monitoring and tracking, which includes at-home fertility/hormone measuring kits, fertility and ovulation monitoring and tracking app, and the men’s fertility test and sperm storage segments as well as fertility preservation services. Notably, among the disruptors and watchlist companies, egg freezing services had the smallest number of companies.

Most firms in the industry are pure-play companies, with the exception of leading disruptors Kindbody and Prelude Fertility. Around half of the disruptors and watchlist companies identified in this report are in the go-to-market stage, with the remainder split between minimum viable product and expansion stages.

The Disruptors


Integrated players LetsGetChecked and Prelude Fertility remain highest funded, followed by financial assistance players

While most disruptors cater to a single segment in the fertility tech ecosystem, one of the highest funded disruptors, Prelude Fertility, distinguishes itself by offering a range of services. Prelude’s offering includes sperm and egg freezing, embryo creation and transfer, and genetic screening for inherited diseases and abnormalities. The highest funded disruptor in this space as of April 2022 was fertility test kit provider, LetsGetChecked.

Most disruptors compete with their segmental peers with similar products, with the exception of at-home fertility/hormone measuring kits for women, where different bodily components are used to measure hormones. For instance, Natural Cycles uses temperature to measure ovulation, whereas Kegg measures cervical fluids to track hormone levels. Furthermore, Apricity (Woom) is an exception to most period and fertility monitoring apps, as it looks to track and give more information on bodily functions, while other apps typically look to predict future cycles using the data.

Funding History

Competitive Analysis


Filter by a segment or companies of your choice
expand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...

Incumbents


Healthcare enterprises offer fertility tech products as extensions to their current offerings; Google has exposure via Fitbit

Incumbents in the fertility tech market include fertility clinics, medical device manufacturers, and testing kit providers. These companies generally opt to produce their own in-house innovations for the fertility tech market, as an extension of their current products and services. For instance, EarlySense offers a range of healthcare monitoring devices and also produces a device to monitor hormones and fertility for women.

DNA Diagnostics Center, a DNA diagnostics and testing provider, acquired Sperm Check in May 2018 to expand their testing to the fertility industry.

In addition to the healthcare enterprises, Google also has interests within the fertility tech industry, through subsidiary Fitbit’s wearables, which offers fertility tracking products, and has invested in a disruptor KindBody, an egg freezing service provider.

In House Development
M&A
Partnership
Investment
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Notable Investors


?
Funding data are powered by Crunchbase
arrow
menuarrow
close

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
Updated in March 2024

Market Sizing

The total addressable market for Fertility Tech in the US is estimated at USD 50.0 billion

The total addressable market (TAM) refers to the total revenue opportunity available for a product or service, while the actual market is the market size based on revenue projections.
The aggregate TAM for Fertility Tech in the US is estimated at USD 50.0 billion. The egg freezing segment dominated the market with a ~91% share of the TAM, while At-home fertility/hormone measuring kit - women, Period and Fertility monitoring and tracking app, and Men’s fertility test segments accounted for 6%, 2%, and 1% respectively. The actual market for Fertility Tech was estimated to be USD 1.8 billion in 2023 and is projected to grow at a CAGR of 17.0% to reach an actual market of USD 3.9 billion by 2028, with a penetration of 7.8%.
Our expansion case estimates the actual market to grow at a CAGR of 22.5% over the next five years, reaching USD 4.9 billion by 2028, implying a penetration of 9.8%. This case considers faster-than-expected growth in penetration rates with more women looking to preserve fertility to focus on their careers, and global period app penetration rates approaching North American levels. However, the negative impact of privacy concerns, lack of insurance coverage, and other such factors may lead to a lower penetration rate, and as such our conservative case estimates the actual market to grow at a CAGR of 10.3% over the next five years reaching USD 2.9 billion, with a penetration of 5.8% by 2028.

Appendix - TAM calculation by segments

1. Egg freezing

Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.